Noticias de investigación
Ver artículos por meses y años
11–16 of 16 artículos
-
ASCO Breast: Analysis Revises Taxane Benefit in Breast Cancer (en inglés)
After surgery for early-stage breast cancer, chemotherapy often is given to destroy any breast cancer cells that may remain in the body and reduce the risk of the cancer coming back (recurrence). Docto...
-
Sequential Docetaxel: No Benefit in Early Breast Cancer (en inglés)
The chemotherapy medicine Taxotere (chemical name: docetaxel) is approved to be used in combination with other chemotherapy medicines to treat early-stage breast cancer. Still, doctors continued to stu...
-
New Chemotherapy Agents Cut Advanced Breast Cancer Mortality in Half (en inglés)
Research has made it clear that new ways to treat and diagnose breast cancer have benefitted women diagnosed with early-stage breast cancer. Women diagnosed with advanced-stage breast cancer also have ...
-
ASCO Breast: Low-Dose, Rapid-Cycle Chemotherapy Active Against Anthracycline-Resistant Disease (en inglés)
Adriamycin (chemical name: doxorubicin) and Ellence (chemical name: epirubicin) are both anthracyclines, a type of chemotherapy medicine. Anthracyclines often are used to treat advanced-stage breast ca...
-
Weekly Taxol best for followup breast cancer care (en inglés)
A study found that getting Taxol (chemical name: paclitaxel) weekly had more benefits than getting Taxol every 3 weeks for women diagnosed with breast cancer that had spread to the lymph nodes or women...
-
Breast cancer survival longer with Taxotere: study (en inglés)
The combination of two chemotherapy medicines, Adriamycin (chemical name: doxorubicin) and Cytoxan (chemical name: cyclophosphamide), often referred to as AC, is commonly used after surgery to treat an...
11–16 of 16 artículos
